Published in J Immunol on August 01, 1989
Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun (2002) 1.45
Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection. Infect Immun (2003) 1.15
Characterization and diagnostic application of Trypanosoma cruzi trypomastigote excreted-secreted antigens shed in extracellular vesicles released from infected mammalian cells. J Clin Microbiol (2016) 0.81
A Novel Vaccine Approach for Chagas Disease Using Rare Adenovirus Serotype 48 Vectors. Viruses (2016) 0.75
Epitope Capsid-Incorporation: New Effective Approach for Vaccine Development for Chagas Disease. Pathog Immun (2016) 0.75
Development of a stable Leishmania expression vector and application to the study of parasite surface antigen genes. Proc Natl Acad Sci U S A (1990) 2.52
Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity (1996) 2.24
A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am J Trop Med Hyg (1989) 1.93
Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg (1991) 1.71
Leishmania donovani chagasi: new clinical variant of cutaneous leishmaniasis in Honduras. Lancet (1991) 1.67
Identification and distribution of New World Leishmania species characterized by serodeme analysis using monoclonal antibodies. Am J Trop Med Hyg (1987) 1.65
Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J Exp Med (2000) 1.63
Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. J Immunol (1997) 1.62
Membrane glycoprotein M-2 protects against Leishmania amazonensis infection. Infect Immun (1988) 1.51
Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infect Immun (1995) 1.44
Tandem arrangement of tubulin genes in the protozoan parasite Leishmania enriettii. Mol Cell Biol (1983) 1.39
T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure. Exp Parasitol (1996) 1.36
Structural and antigenic characterization of a species- and promastigote-specific Leishmania mexicana amazonensis membrane protein. J Immunol (1987) 1.27
Monoclonal antibodies that distinguish subspecies of Leishmania braziliensis. J Immunol (1982) 1.27
Production and characterization of species-specific monoclonal antibodies against Leishmania donovani for immunodiagnosis. J Immunol (1984) 1.26
Characterization and classification of leishmanial parasites from humans, wild mammals, and sand flies in the Amazon region of Brazil. Am J Trop Med Hyg (1991) 1.25
Monoclonal antibodies specific for Leishmania tropica. I. Characterization of antigens associated with stage- and species-specific determinants. J Immunol (1983) 1.19
Molecular cloning and characterization of the immunologically protective surface glycoprotein GP46/M-2 of Leishmania amazonensis. Proc Natl Acad Sci U S A (1990) 1.14
Serodiagnostic assay for visceral leishmaniasis employing monoclonal antibodies. Trans R Soc Trop Med Hyg (1987) 1.11
Biochemical and molecular characterization of Leishmania pifanoi amastigotes in continuous axenic culture. Mol Biochem Parasitol (1991) 1.11
Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells. Eur J Immunol (1996) 1.05
Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8+ T cells. J Immunol (1997) 1.05
Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages. J Exp Med (1995) 1.04
Studies on the attachment of Leishmania flagella to sand fly midgut epithelium. J Protozool (1990) 1.01
Developmental life cycle of Leishmania--cultivation and characterization of cultured extracellular amastigotes. J Eukaryot Microbiol (1993) 1.00
Mucocutaneous leishmaniasis in Colombia: Leishmania braziliensis subspecies diversity. Am J Trop Med Hyg (1985) 0.97
Leishmania amazonensis: cultivation and characterization of axenic amastigote-like organisms. Exp Parasitol (1996) 0.96
The immunologically protective P-4 antigen of Leishmania amastigotes. A developmentally regulated single strand-specific nuclease associated with the endoplasmic reticulum. J Biol Chem (2000) 0.94
Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants. J Immunol (1988) 0.93
Flagellar membrane and paraxial rod proteins of Leishmania: characterization employing monoclonal antibodies. J Protozool (1990) 0.93
Characterization of Leishmania colombiensis sp. n (Kinetoplastida: Trypanosomatidae), a new parasite infecting humans, animals, and phlebotomine sand flies in Colombia and Panama. Am J Trop Med Hyg (1991) 0.93
In vivo protection against Leishmania mexicana mediated by monoclonal antibodies. J Immunol (1983) 0.92
The biosynthesis, processing, and immunolocalization of Leishmania pifanoi amastigote cysteine proteinases. Mol Biochem Parasitol (1994) 0.91
Evolution of nuclear DNA and the occurrence of sequences related to new small chromosomal DNAs in the trypanosomatid genus Endotrypanum. Mol Biochem Parasitol (1990) 0.90
Extracellular cultivation and morphological characterization of amastigote-like forms of Leishmania panamensis and L. braziliensis. J Protozool (1989) 0.89
Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis. Vaccine (2006) 0.88
Identification of two distinct cysteine proteinase genes of Leishmania pifanoi axenic amastigotes using the polymerase chain reaction. Mol Biochem Parasitol (1993) 0.87
Prophylactic immunization against experimental Leishmania donovani infection by use of a purified protein vaccine. J Infect Dis (1990) 0.87
Production of a specific monoclonal antibody for the identification of Leishmania (Leishmania) venezuelensis. Am J Trop Med Hyg (1990) 0.87
Cutaneous leishmaniasis in western Venezuela caused by infection with Leishmania venezuelensis and L. braziliensis variants. Trans R Soc Trop Med Hyg (1992) 0.87
Leishmania amazonensis: the Asian rhesus macaques (Macaca mulatta) as an experimental model for study of cutaneous leishmaniasis. Exp Parasitol (1996) 0.87
Monoclonal antibodies for the identification of New World Leishmania species. Mem Inst Oswaldo Cruz (1996) 0.86
Biochemical characterization of the protective membrane glycoprotein GP46/M-2 of Leishmania amazonensis. Mol Biochem Parasitol (1991) 0.85
Biochemical and biological characterization of the protective Leishmania pifanoi amastigote antigen P-8. Infect Immun (2001) 0.84
Leishmania pifanoi amastigote antigen P-4: epitopes involved in T-cell responsiveness in human cutaneous leishmaniasis. Infect Immun (1998) 0.84
Cellular trafficking in trypanosomatids: a new target for therapies? Int J Parasitol (2001) 0.83
Cutaneous leishmaniasis: review of 59 cases seen at the National Institutes of Health. Clin Infect Dis (1992) 0.82
Identification, using isoenzyme electrophoresis and monoclonal antibodies, of Leishmania isolated from humans and wild animals of Ecuador. Am J Trop Med Hyg (1989) 0.82
Trafficking of cysteine proteinase to Leishmania lysosomes: lack of involvement of glycosylation. Mol Biochem Parasitol (2000) 0.81
Purification and characterization of an 80-kilodalton membrane protein from Leishmania donovani. Infect Immun (1988) 0.81
Molecular and biologic characterization of Leishmania parasites implicated in an epidemic outbreak in northwestern Argentina. Parasitol Res (2000) 0.81
Leishmaniasis in Brazil: XXIII. The identification of Leishmania braziliensis braziliensis in wild-caught neotropical sandflies using monoclonal antibodies. Trans R Soc Trop Med Hyg (1987) 0.80
Brazilian Leishmania stocks phenotypically similar to Leishmania major. Am J Trop Med Hyg (1985) 0.80
Intracellular signaling transduction in the differentiation of Trypanosoma cruzi: role of cAMP. Arch Biol Med Exp (Santiago) (1988) 0.80
Extracellular amastigote-like forms of Leishmania panamensis and L. braziliensis. II. Stage- and species-specific monoclonal antibodies. J Protozool (1989) 0.79
T cell responses to crude and defined leishmanial antigens in patients from the lower Amazon region of Brazil infected with different species of Leishmania of the subgenera Leishmania and Viannia. Parasite Immunol (1998) 0.79
Evaluation of amastigote reactive cells in human cutaneous leishmaniasis caused by Leishmania aethiopica. Clin Exp Immunol (2003) 0.78
Monoclonal antibodies specific for members of the genus Endotrypanum. J Protozool (1989) 0.77
Leishmania amastigote target antigens: the challenge of a stealthy intracellular parasite. Parasitol Today (1998) 0.77
Epitope tagging in leishmania: testing of commercial monoclonal antibodies. Parasitol Today (1998) 0.76
Leishmania mexicana pifanoi: antigenic characterization of promastigote and amastigote stages by solid phase radioimmunoassay. J Parasitol (1984) 0.76
Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donors. Scand J Immunol (2004) 0.76
A simple procedure for the isolation of leishmanial parasites and for the recovery of parasite virulence in avirulent stocks. Trans R Soc Trop Med Hyg (1984) 0.75
Evidence for a recent mutation giving rise to a truncated copy of a cysteine proteinase gene in Leishmania pifanoi. Parasitol Int (2000) 0.75
The identification of membrane glycoconjugates in Leishmania species. J Parasitol (1988) 0.75